Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications.

Antimicrobial resistance antimicrobial surveillance. antimicrobial stewardship antimicrobial utilization national action plan pakistan

Journal

Expert review of anti-infective therapy
ISSN: 1744-8336
Titre abrégé: Expert Rev Anti Infect Ther
Pays: England
ID NLM: 101181284

Informations de publication

Date de publication:
Jan 2022
Historique:
pubmed: 27 5 2021
medline: 22 4 2022
entrez: 26 5 2021
Statut: ppublish

Résumé

The emergence of antimicrobial resistance (AMR) is a threat to public health. In 2015, the World Health Organization (WHO) introduced a global action plan to tackle AMR in the World Health Assembly. Pakistan's national action plan (NAP) for AMR was released in May 2017 by the Ministry of National Health Services. Based on the NAP, strategies have been initiated on a national and provincial scale in Pakistan. This narrative review of the five components of the Pakistan NAP has been undertaken to discuss some of the challenges in implementation of the NAP for AMR in Pakistan including different opinions and views of key stakeholders, combined with suggestions on potential ways to reduce the burden of the AMR. Going forward, healthcare authorities should focus on screening and monitoring of all the objectives of the NAP by establishing proper policies as well as promoting antimicrobial stewardship interventions and Infection prevention and control (IPC) practices. Overall, the comprehensive strengthening of the healthcare system is required to adequately implement the NAP, tackle continued inappropriate antimicrobial use and high AMR rates in Pakistan.

Identifiants

pubmed: 34038294
doi: 10.1080/14787210.2021.1935238
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

71-93

Auteurs

Zikria Saleem (Z)

Department of Pharmacy Practice, Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.

Brian Godman (B)

Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, UK.
School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, South Africa.
School of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town Malaysia.

Faiza Azhar (F)

Department of Pharmaceutical Chemistry, University College of Pharmacy, University of the Punjab, Lahore, Pakistan.

Aubrey C Kalungia (AC)

Department of Pharmacy, University of Zambia, Lusaka, Zambia.

Joseph Fadare (J)

Department of Pharmacology and Therapeutics, Ekiti State University, Ado-Ekiti, Nigeria.

Sylvia Opanga (S)

Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, Nairobi, Kenya.

Vanda Markovic-Pekovic (V)

Department of Social Pharmacy, Faculty of Medicine, University of Banja Luka, Republic of Srpska, Bosnia and Herzegovina.

Iris Hoxha (I)

Department of Pharmacy, Faculty of Medicine, University of Medicine Tirana, Albania.

Amna Saeed (A)

Department of Pharmacy Practice, Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.

Manal Al-Gethamy (M)

Alnoor Specialist Hospital Makkah, Department of Infection Prevention & Control Program, Makkah, Kingdom of Saudi Arabia.

Abdul Haseeb (A)

Department of Clinical Pharmacy, College of Pharmacy, Umm Al Qura University, Makkah, Kingdom of Saudi Arabia.

Muhammad Salman (M)

Department of Pharmacy Practice, Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.

Ayaz Ali Khan (AA)

Department of Pharmacy Practice, Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.

Muhammad Umer Nadeem (MU)

Department of Pharmaceutical Chemistry, University College of Pharmacy, University of the Punjab, Lahore, Pakistan.

Inaam Ur Rehman (IU)

Department of Pharmaceutical Chemistry, University College of Pharmacy, University of the Punjab, Lahore, Pakistan.

Muhammad Usman Qamar (MU)

Department of Microbiology, Faculty of Life Sciences, Government College University Faisalabad, Faisalabad, Pakistan.

Afreenish Amir (A)

Department of Microbiology, National Institute of Health Islamabad, Pakistan.

Aamer Ikram (A)

Department of Microbiology, National Institute of Health Islamabad, Pakistan.

Muhammad Azmi Hassali (MA)

School of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town Malaysia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH